NISA INVESTMENT ADVISORS, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 937615 ST. LOUIS, MO

Position in DSGN

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$157,727

+$46,818 QoQ

Shares Held

14,824

+25.4% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

NISA INVESTMENT ADVISORS, LLC holds $80,192,979 across 242 Biotechnology names. DSGN ranks #33 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	58,183	$25,981,036
2	REGN	Regeneron Pharmaceuticals, Inc.	19,771	$15,275,865
3	EXEL	Exelixis, Inc.	107,496	$4,610,503
4	TECH	BIO-TECHNE Corp	72,813	$3,805,207
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,357	$3,095,950
6	INCY	Incyte Corp	31,835	$2,996,310
7	ROIV	Roivant Sciences Ltd.	81,912	$2,268,962
8	INSM	INSMED Inc	13,447	$2,198,853

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$157,727	14,824	+25.4%	Shares	Sole	2026-04-30
2025-12-31	$110,909	11,824	0.0%	Shares	Sole	2026-01-15
2025-09-30	$89,034	11,824	0.0%	Shares	Sole	2025-10-23
2025-06-30	$39,846	11,824	-0.8%	Shares	Sole	2025-07-31
2025-03-31	$45,995	11,916	+0.5%	Shares	Sole	2025-04-30
2024-12-31	$73,145	11,855	-0.4%	Shares	Sole	2025-01-17
2024-09-30	$64,048	11,905	+0.4%	Shares	Sole	2024-10-24
2024-06-30	$39,714	11,855	+2.6%	Shares	Sole	2024-07-19
2024-03-31	$46,586	11,560	0.0%	Shares	Sole	2024-05-02
2023-12-31	$30,634	11,560	+38433.3%	Shares	Sole	2024-01-25
2023-09-30	$70	30	+76.5%	Shares	Sole	2023-11-02
2023-03-31	$98	17	-50.0%	Shares	Sole	2023-05-02
2022-09-30	$568	34	—	Shares	Sole	2022-11-07
No filing history on record for this holder in this stock.